- Home
- NUAIW vs FBIOP Comparison
NUAIW vs FBIOP Comparison
Compare NUAIW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUAIW | FBIOP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NUAIW | FBIOP |
|---|---|---|
| Price | $3.55 | $17.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.4K | 6.7K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.89 | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | $885,400.00 | ★ $63,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.22 |
| Revenue Growth | ★ 66.18 | 9.69 |
| 52 Week Low | $0.13 | $6.27 |
| 52 Week High | $3.07 | $21.43 |
Technical Indicators
Market Signals| Indicator | NUAIW | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 72.27 | 26.72 |
| Support Level | $1.74 | $12.71 |
| Resistance Level | N/A | $18.91 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 89.59 | 42.58 |
Price Performance
Historical ComparisonAbout NUAIW New Era Energy & Digital Inc. Warrants
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.